ATLAS / Macro Radar / Reporting / KROS

Keros Therapeutics, Inc. (KROS) reporting calendar

Keros Therapeutics, Inc. files periodic reports with the SEC as KROS on Nasdaq. Atlas tracks 25 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
24 Jul 2026 – 19 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
25

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 37 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001664710-26-000030
10-K31 Dec 20254 Mar 202663 days0001664710-26-000018
10-Q30 Sep 20255 Nov 202536 days0001664710-25-000089
10-Q30 Jun 20256 Aug 202537 days0001664710-25-000070
10-Q31 Mar 20256 May 202536 days0001664710-25-000046
10-K31 Dec 202426 Feb 202557 days0001664710-25-000018
10-Q30 Sep 20246 Nov 202437 days0001664710-24-000091
10-Q30 Jun 20247 Aug 202438 days0001664710-24-000068
10-Q31 Mar 20248 May 202438 days0001664710-24-000039
10-K31 Dec 202328 Feb 202459 days0001664710-24-000017
10-Q30 Sep 20236 Nov 202337 days0001664710-23-000066
10-Q30 Jun 20237 Aug 202338 days0001664710-23-000050
10-Q31 Mar 20234 May 202334 days0001664710-23-000030
10-K31 Dec 20223 Mar 202362 days0001664710-23-000021
10-Q30 Sep 20223 Nov 202234 days0001664710-22-000056
10-Q30 Jun 20224 Aug 202235 days0001664710-22-000040
10-Q31 Mar 20225 May 202235 days0001664710-22-000019
10-K31 Dec 20219 Mar 202268 days0001664710-22-000011
10-Q30 Sep 20214 Nov 202135 days0001664710-21-000065
10-Q30 Jun 20215 Aug 202136 days0001664710-21-000053
10-Q31 Mar 20216 May 202136 days0001664710-21-000025
10-K31 Dec 202025 Mar 202184 days0001664710-21-000018
10-Q30 Sep 202010 Nov 202041 days0001664710-20-000050
10-Q30 Jun 202013 Aug 202044 days0001664710-20-000027
10-Q31 Mar 202022 May 202052 days0001664710-20-000006

Source: SEC EDGAR company submissions for CIK 0001664710. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.